Literature DB >> 20113371

Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.

Matthew D Morgan1, Clara J Day, Karen P Piper, Naeem Khan, Lorraine Harper, Paul A Moss, Caroline O S Savage.   

Abstract

An increased proportion of CD4(+) CD25(+) T cells has been reported in Wegener's granulomatosis (WG) and may represent an accumulation of regulatory T cells (Treg). CD25 is also expressed on recently activated effector T cells. We have determined the relative proportion of these subsets in a large patient cohort. The fraction of Treg in peripheral blood mononuclear cells from patients and healthy controls was determined by assessment of Foxp3 expression on CD4(+) CD25(+) T cells. The functional activity of Treg was determined by their ability to suppress proliferation and cytokine production in response to proteinase-3. Although WG patients demonstrated an increased fraction of CD4(+) CD25(+) T cells, the percentage of Foxp3-positive cells was decreased. In addition, the percentage of Treg was inversely related to the rate of disease relapse. CD4(+) CD25(hi) T cells were able to suppress T-cell proliferation to proteinase-3 in healthy controls and anti-neutrophil cytoplasm antibody (ANCA)- negative patients (at time of sampling) but not in ANCA-positive patients. In patients with active disease, an increased proportion of CD4(+) Foxp3(+) cells was associated with a more rapid disease remission. Patients with WG demonstrate abnormalities in the number and function of Treg and this is most pronounced in those with most active disease. This information is of value in understanding the pathogenesis and potential treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113371      PMCID: PMC2855794          DOI: 10.1111/j.1365-2567.2009.03213.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

Review 2.  Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis.

Authors:  Peter Lamprecht; Hilke Bruhl; Anika Erdmann; Konstanze Holl-Ulrich; Elena Csernok; Ulrike Seitzer; Matthias Mack; Alfred C Feller; Eva Reinhold-Keller; Wolfgang L Gross; Antje Muller
Journal:  Clin Immunol       Date:  2003-07       Impact factor: 3.969

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Authors:  Hong Xiao; Peter Heeringa; Peiqi Hu; Zhi Liu; Minglang Zhao; Yasuaki Aratani; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis.

Authors:  Ricardo Giscombe; Xiongbiao Wang; Deren Huang; Ann Kari Lefvert
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene.

Authors:  Yihua Zhou; Ricardo Giscombe; Deren Huang; Ann Kari Lefvert
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

8.  Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.

Authors:  Wilhelm H Schmitt; E Christiaan Hagen; Irmgard Neumann; Rainer Nowack; Luis Felipe Flores-Suárez; Fokko J van der Woude
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

Review 9.  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Authors:  C Mukhtyar; O Flossmann; B Hellmich; P Bacon; M Cid; J W Cohen-Tervaert; W L Gross; L Guillevin; D Jayne; A Mahr; P A Merkel; H Raspe; D Scott; J Witter; H Yazici; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2007-10-02       Impact factor: 19.103

10.  Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

Authors:  Leonie S Taams; Milica Vukmanovic-Stejic; Jay Smith; Padraic J Dunne; Jean M Fletcher; Fiona J Plunkett; Saskia B Ebeling; Giovanna Lombardi; Malcolm H Rustin; Johannes W J Bijlsma; Floris P J G Lafeber; Mike Salmon; Arne N Akbar
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

View more
  49 in total

Review 1.  ANCA-associated vasculitides--advances in pathogenesis and treatment.

Authors:  Min Chen; Cees G M Kallenberg
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

Review 2.  Biomarkers in ANCA-associated vasculitis.

Authors:  Lindsay Lally; Robert F Spiera
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

Review 3.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

4.  A case of (double) ANCA-negative granulomatosis with polyangiitis (Wegener's).

Authors:  Tetsuya Kashiwagi; Naoaki Hayama; Emiko Fujita; Keiko Hara; Akiko Mii; Yukinari Masuda; Yasuhiko Iino; Akira Shimizu; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-06-26

Review 5.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 6.  Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Authors:  Damien Noone; Diane Hebert; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-09-05       Impact factor: 3.714

7.  Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.

Authors:  Joanna R Ghali; Maliha A Alikhan; Stephen R Holdsworth; A Richard Kitching
Journal:  Immunology       Date:  2016-10-10       Impact factor: 7.397

Review 8.  Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Authors:  C O S Savage
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

Review 9.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 10.  Pathophysiology of ANCA-associated small vessel vasculitis.

Authors:  Cees G M Kallenberg
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.